BioCentury
ARTICLE | Financial News

Teva completes follow-on

December 7, 2015 8:00 AM UTC

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Autoimmune, Neurology, Biosimilars Date completed: 2015-12-02 Type: Follow-on Raised: $3.4 billion Shares: 54 million Pri...